Parathyroid carcinoma is an uncommon cause of PTH-dependent hypercalcemia. The
collective published experience with this rare neoplasm has provided a distinctive clinical …

Background Parathyroid cancer is rare and often fatal. This review provides an in-depth
analysis of 330 clinical cases reported in detail. These data are used to inform a proposal for …

This volume covers tumors of the pituary, the thyroid and parathyroid, the adrenal gland, the
endocrine pancreas, and inherited tumor syndromes. Each entity is extensively discussed …

Background: Management of inoperable parathyroid carcinoma presents a challenge
because until recently, effective medical therapy was not available. Morbidity and mortality …

Offering a comprehensive, multidisciplinary approach to head and neck oncology, Cancer of
the Head and Neck, Fifth Edition, delivers authoritative guidance to the entire head and neck …

Background Parathyroid cancer has a poor mid-term prognosis, often because of local
recurrence, observed in half of all patients. Modern diagnostic workup increasingly enables …

Parathyroid carcinoma is an uncommon malignancy. It accounts for less than 1% of cases of
primary hyperparathyroidism (HPT). It is manifested by severe hypercalcemia and up to 50 …

Parathyroid carcinoma is an uncommon endocrine malignancy that was first described in
1904 by de Quervain. 1 de Quervain described a metastatic, nonfunctioning parathyroid …

Background The best surgical approach to parathyroid cancer is disputed.
Recommendations vary and are built on incoherent evidence. High rates of recurrence and …

Pharmacological treatment of hypercalcemia is essential for patients with parathyroid
carcinoma and intractable primary hyperparathyroidism (PHPT). Use of the calcimimetic …